Sociodemographic characteristics and quality-of-life of Greek menopausal women treated with hormone therapy

dc.contributor.author	Βλάχου, Ευγενία Δ.	el
dc.contributor.author	Θεοδοσοπούλου, Ελένη	el
dc.contributor.author	Καβγά - Παλτόγλου, Άννα	el
dc.contributor.author	Φασόη - Μπαρκά, Γεωργία, Γ.	el
dc.contributor.author	Καλεμικεράκης, Ιωάννης	el
dc.date.accessioned	2014-07-20T22:40:35Z
dc.date.available	2014-07-20T22:40:35Z
dc.date.issued	2014-07-21
dc.identifier.uri	http://hdl.handle.net/11400/1505
dc.rights	Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/us/	*
dc.source	www.hsj.gr	en
dc.subject	Menopause--Hormone therapy
dc.subject	Older women--Health and hygiene
dc.subject	Anxiety in old age
dc.subject	Depression in women
dc.subject	Εμμηνόπαυση
dc.subject	Ορμονοθεραπεία
dc.subject	Γυναικεία υγεία
dc.subject	Ποιότητα ζωής
dc.subject	Άγχος
dc.subject	Κατάθλιψη
dc.subject	Quality of life
dc.title	Sociodemographic characteristics and quality-of-life of Greek menopausal women treated with hormone therapy	en
heal.type	journalArticle
heal.generalDescription	Research article	en
heal.classification	Ιατρική
heal.classification	Γυναικολογία
heal.classificationURI	N/A-Ιατρική
heal.classificationURI	N/A-Γυναικολογία
heal.keywordURI	http://id.loc.gov/authorities/subjects/sh88000970
heal.keywordURI	http://id.loc.gov/authorities/subjects/sh2010104382
heal.keywordURI	http://id.loc.gov/authorities/subjects/sh90002608
heal.keywordURI	http://id.loc.gov/authorities/subjects/sh97005658
heal.contributorName	Κελέση, Μάρθα	el
heal.contributorName	Γκοβίνα, Ουρανία	el
heal.language	en
heal.access	free
heal.recordProvider	Τεχνολογικό Εκπαιδευτικό Ίδρυμα Αθήνας.Σχολή Επαγγελμάτων Υγείας και Πρόνοιας. Τμήμα Νοσηλευτικής	en
heal.publicationDate	2014-07
heal.bibliographicCitation	Vlachou, E., Theodosopoulou, E., Kavga-Paltoglou, A. & Fasoi-Barka, G. (July 2014). Sociodemographic characteristics and quality-of-life of Greek menopausal women treated with hormone therapy. “Health Science Journal”. 8(3):318-332.	en
heal.abstract	Background: Menopause, a significant and unavoidable change of the normal female biological process, has attracted science’s attention since ancient times. In recent decades, women claim the right to social production and better quality of their remaining life. The aim of this descriptive, comparative and prospective study was to investigate the demographic characteristics and the quality-of-life of Greek postmenopausal women who were taking Menopausal Hormone Therapy (MHT) compared with those not taking. Method and Material: The sample consisted of 216 postmenopausal women aged 40 to 60 years old who were divided into two groups and evaluated at the beginning of the research, as well as six months later, in a period of 19 months. The MHT group consisted of 100 women who were taking MHT and the non-MHT group consisted of 116 women who were not. A questionnaire for demographic data was used, as well the Greene Climacteric Scale (GC) and the Menopause-Specific Quality-of-life Questionnaire (MENQOL). Results: 46.3% of women were taking MHT, while the 53.7% were not. By comparing the two groups, it became apparent that the MHT group of women were more likely to have grown up in an urban area (p = 0.04), to have higher education (p <0.001), to have jobs of demanding responsibility (p = 0.008) and to have lower body weight (p=0.002). The non-MHT group was found to have statistically significant more severe symptoms in the GC scale from the MHT group in both assessments (p<0.001). Multiple linear regression analysis showed that factors of the model explain 49.4% of the GC scale. Evaluating the quality-of-life using the MENQOL questionnaire, a statistically significant difference was found in both assessments (p<0.001), with the non-MHT group showing a lower quality-of-life compared to the MHT group, in both assessments. Multiple linear regression analysis showed that the factors of the model explain 54.8% of the MENQOL, meaning that women with higher education have a better quality-of-life compared with the non-MHT group. In correlating the two scales with the Pearson coefficient, it was found a statistically significant positive correlation (r=0.845 and p<0.001). Conclusions: MHT seems to provide significant benefit in improving quality-of-life during menopause. However, the administration of this treatment should always be individualized and used with caution. The nurse’s advisory role is of high value to the women’s decision-making on MHT.	en
heal.publisher	Μαρβάκη, Χριστίνα	el
heal.journalName	Health Science Journal	en
heal.journalType	peer-reviewed
heal.fullTextAvailability	true